Skip to content

Utility of the Audible Alert in Current Generation Medtronic Implantable Cardioverter-defibrillators

Investigation of the Utility of the Audible Alert in Current Generation Medtronic ICDs

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01605500
Enrollment
100
Registered
2012-05-25
Start date
2012-06-30
Completion date
2015-06-30
Last updated
2016-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients With a Generation 2 Medtronic Implantable Cardioverter-defibrillator(ICD)

Keywords

ICD

Brief summary

The purpose of this study is to determine whether the alert tones emitted by the latest generation of Medtronic implantable cardioverter-defibrillators (ICDs) are audible to patients. ICD patients can have difficulties hearing the beeps, which are designed to notify patients of possible lead or generator malfunction. In fact, the only published study of this issue, conducted at Englewood Hospital and Medical Center, revealed that only 50% of patients with older Medtronic devices were able to hear alerts. Since then, modifications to the alert have been made by Medtronic. This study will establish the real-world value of these changes and also provide useful in vivo information regarding the validity of the in vitro techniques which have been used thus far to design the Patient Alert feature.

Detailed description

There will be a single study visit. In a quiet examination room, the Patient Alert tones will be demonstrated to the subjects. Subsequently, this will be repeated with a wall air conditioner turned on. The subjects will then be asked to complete a three-part questionnaire regarding their perceptions of the Patient Alert tones. Data analysis will include overall ability to hear tones, as well as subgroup analysis according to gender, age, and BMI. Simultaneously, in order to calculate the loudness of the alert tones, digital recordings will be obtained using two microphones located near the subject. These digital recordings will be analyzed, and a loudness value will be calculated. The loudness value is a calculated index, devised by Medtronic, which incorporates frequency and intensity. Data analysis will include a correlation between loudness value and patient characteristics, and between loudness value and ability of subjects to perceive the tones.

Interventions

None listed

Sponsors

Medtronic
CollaboratorINDUSTRY
Englewood Hospital and Medical Center
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Previous insertion of a Medtronic Generation 2 ICD (Consulta, Secura, Concerto II, Virtuoso II, Maximo II devices) not fewer than 7 days prior to study entry * Able to provide informed consent

Exclusion criteria

* Known deafness * Recent (fewer than 6 weeks) ICD pocket surgery * Non-Generation 2 Medtronic ICD * Pocket hematoma * Pocket infection

Design outcomes

Primary

MeasureTime frameDescription
Audibilityparticipants will be tested during a single, routine clinic visit - the average duration for each patient will be 30 minuteshow frequently patients are able to detect the alert tones

Secondary

MeasureTime frameDescription
Loudness value1 monthdigital recordings of the tones will be analyzed to determine the loudness value loudness value is a calculated index, devised by Medtronic, which incorporates frequency and intensity

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026